Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Title:
PLoS ONE
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
1932-6203
Publication date
(Electronic):
4
May
2017
Publication date Collection: 2017
Volume: 12
Issue: 5
Electronic Location Identifier: e0176846
Affiliations
[1
]Department of Cardiology, Faculty of Health, Örebro University, Örebro, Sweden
[2
]Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University,
Örebro, Sweden
[3
]Department of Occupational and Environmental Medicine, Örebro University, Örebro,
Sweden
[4
]Department of Medical Science, Uppsala University, Uppsala, Sweden
[5
]Sahlgrenska Academy at Sahlgrenska University Hospital, Göteborg, Sweden
University of Bologna, ITALY
Author notes
Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following
competing interests: KMH is a former employee of AstraZeneca R&D. This does not alter
our adherence to PLOS ONE policies on sharing data and materials. The other authors
have declared that no competing interests exist.
-
Conceptualization: TA AM IB OF KMH NE DP.
-
Formal analysis: TA AM IB.
-
Writing – original draft: TA.
-
Writing – review & editing: TA AM IB OF KMH NE DP.
Author information
Article
Publisher ID:
PONE-D-16-50301
DOI: 10.1371/journal.pone.0176846
PMC ID: 5417522
PubMed ID: 28472091
SO-VID: b34f8f68-23fc-42c2-9d52-dafce4fa7bcd
Copyright © © 2017 Andersson et al
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
Funded by: Research committee of Orebro University
Award ID: OLL 2012-265231
Award Recipient
:
ORCID: http://orcid.org/0000-0001-5055-3728
Tommy Andersson
The study was supported by a grant from the Research Committee of örebro University
(OLL 2012-265231), AstraZeneca R&D Mölndal and the örebro Heart Foundation. AstraZeneca
provided support in the form of salary for one author [KMH, at the time an employee
of AstraZeneca] but did not have any additional role in the study design, data collection
and analysis, decision to publish, or preparation of the manuscript. The specific
roles of the authors are articulated in the author contribution section.
Subject:
Research Article
Subject:
Medicine and Health Sciences
Subject:
Cardiology
Subject:
Arrhythmia
Subject:
Atrial Fibrillation
Subject:
Medicine and Health Sciences
Subject:
Neurology
Subject:
Cerebrovascular Diseases
Subject:
Stroke
Subject:
Medicine and Health Sciences
Subject:
Vascular Medicine
Subject:
Stroke
Subject:
Medicine and Health Sciences
Subject:
Diagnostic Medicine
Subject:
Signs and Symptoms
Subject:
Infarction
Subject:
Medicine and Health Sciences
Subject:
Pathology and Laboratory Medicine
Subject:
Signs and Symptoms
Subject:
Infarction
Subject:
Medicine and Health Sciences
Subject:
Diagnostic Medicine
Subject:
Signs and Symptoms
Subject:
Hemorrhage
Subject:
Medicine and Health Sciences
Subject:
Pathology and Laboratory Medicine
Subject:
Signs and Symptoms
Subject:
Hemorrhage
Subject:
Medicine and Health Sciences
Subject:
Vascular Medicine
Subject:
Hemorrhage
Subject:
Medicine and Health Sciences
Subject:
Pulmonology
Subject:
Chronic Obstructive Pulmonary Disease
Subject:
Medicine and Health Sciences
Subject:
Nephrology
Subject:
Renal Failure
Subject:
Medicine and Health Sciences
Subject:
Oncology
Subject:
Cancers and Neoplasms
Subject:
Neoplasms
Subject:
People and Places
Subject:
Population Groupings
Subject:
Ethnicities
Subject:
Swedes